Jacqueline F Moloney, who serves on the board of MKS Instruments Inc. (NASDAQ: MKSI), reported the sale of 829 shares of common stock on February 20, 2026, in a Form 4 filing with the Securities and Exchange Commission. The shares were sold at $247.55 apiece, producing a total transaction value of $205,218. After completing the trade, Moloney directly holds 10,733.304 shares of the company's common stock.
The insider sale coincides with MKSI trading at $251.79 and a one-year return of 154% for the stock. InvestingPro analysis cited in company materials indicates the stock presently appears overvalued relative to its Fair Value. The company notes that a comprehensive Pro Research Report covering MKSI and more than 1,400 U.S. equities is available for investors seeking additional valuation and performance detail.
Alongside the reported insider transaction, MKS Instruments released fourth-quarter financial results that outpaced analyst expectations. The company posted earnings per share of $2.47, compared with analyst projections of $2.30. Revenue for the quarter reached $1.03 billion, topping the consensus estimate of $995.32 million and representing a 10.5% increase versus the prior year.
Management provided first-quarter revenue guidance that was above consensus, citing continued strength in the Electronics & Packaging segment and increased shipments in the Semi division as contributors to the outlook. These operational notes accompanied the earnings release and the guidance update.
Market analysts reacted to the quarterly report. Needham raised its price target for MKS Instruments to $300 while keeping a Buy rating. KeyBanc reiterated an Overweight rating with a $250 price target. KeyBanc's assessments were supported by the company's fourth-quarter results, which exceeded both consensus estimates and KeyBanc's internal expectations for earnings and revenue.
Despite the stronger-than-expected results and the positive analyst actions, MKS Instruments' shares declined in after-hours trading, falling 7.3%. The combination of an insider sale, a valuation assessment indicating potential overvaluation, robust quarterly results, and divergent market reaction frames the current backdrop for MKSI investors.
Contextual note: For investors interested in deeper analysis, the company references a Pro Research Report that provides further valuation and performance metrics for MKSI and other covered U.S. equities.